AIC
ELDN icon

AWM Investment Company’s Eledon Pharmaceuticals ELDN Stock Holding History

AWM Investment Company’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Hold
1,100,000
– – 0.38% 67
2026
Q1 		$3.39M Hold
1,100,000
– – 0.38% 64
2025
Q4 		$1.66M Buy
+1,100,000
New +$2.61M 0.16% 90
2025
Q3 		– Sell
-1,100,473
Closed -$2.98M – 105
2025
Q2 		$2.98M Hold
1,100,473
– – 0.33% 70
2025
Q1 		$3.73M Hold
1,100,473
– – 0.51% 54
2024
Q4 		$4.53M Buy
+1,100,473
New +$4.34M 0.55% 53
2015
Q1 		– Sell
-617
Closed -$1.47M – 137
2014
Q4 		$1.47M Buy
+617
New +$1.46M 0.2% 98

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

AWM Investment Company's ELDN Position: Q2 2026 in Review

AWM Investment Company held its Eledon Pharmaceuticals (ELDN) position steady in Q2 2026 at 1,100,000 shares worth $4.33M. The position accounts for 0.38% of the portfolio, ranked #67.

AWM Investment Company first reported a position in ELDN in Q4 2014 and has held it in 7 quarters since. The position peaked at $4.53M in Q4 2024. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • AWM Investment Company held 1,100,000 shares of Eledon Pharmaceuticals worth $4.33M as of Q2 2026.
  • AWM Investment Company left its Eledon Pharmaceuticals share count unchanged in Q2 2026.
  • Eledon Pharmaceuticals made up 0.38% of AWM Investment Company's portfolio in Q2 2026, its #67 holding.
  • AWM Investment Company first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 7 quarters since.
  • AWM Investment Company's Eledon Pharmaceuticals position peaked at $4.53M in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.